EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study

Mengxia Liu, Pengcheng Liu, JianBin Li, Yiping Huang, Rui Wu

PeerJ · 29.11.2024 · 12 · e18631

DOI: 10.7717/peerj.18631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 29.11.2024. Verfasst von Mengxia Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synovial Membrane, Janus Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease, characterized by significant individual variations in treatment response. Predicting treatment response remains a formidable challenge. This study aims to identify predictors within the synovium associated with the response to JAK inhibitor therapy in RA patients, employing a retrospective approach.

Methods

A retrospective analysis was conducted on 27 RA patients who underwent synovial biopsy and received JAK inhibitor therapy for at least three months at our center, from January to November 2023. These patients had comprehensive clinical records. Based on their response to JAK inhibitor therapy, as measured by the ACR20 criteria, they were categorized into non-responder and responder groups. We compared clinical data (including sex, age, disease duration), laboratory findings (RF, ACPA, ESR, CRP, etc .), DAS28-CRP scores, and synovial pathology features—such as synovial lining hyperplasia, neovascularization, stromal activation, inflammatory infiltration, and the expression of CD3, CD20, CD68, and CD138 markers in the synovium—between the two groups.

Results

The rate of non-responder to JAKi was found to be 33.3% (nine cases out of a total of 27 patients). Non-responders, when compared to responders, exhibited longer disease duration, more pronounced synovial neovascularization alongside reduced infiltration of labeled CD20+ and CD138+ cells in the synovium. Multivariate regression analysis identified synovial neovascularization and disease duration as independent predictors of a poor response to JAK inhibitor treatment.

Conclusions

The presence of vascular phenotype with low inflammation within the synovium of RA patients is an indicator of poor response to JAK inhibitor therapy, highlighting its potential as a predictive marker for treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynovial MembraneJanus Kinase InhibitorsHumansMaleFemaleMiddle AgedRetrospective StudiesPilot ProjectsPhenotypeAgedAdultAntirheumatic AgentsTreatment Outcome

Stichwörter der Autor:innen

JAK inhibitorsRheumatoid arthritisSynovial biopsyTreatment response

Substanzen

Janus Kinase InhibitorsAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.

Zitieren

APA

Liu, M., Liu, P., Li, J., Huang, Y., & Wu, R. (2024). Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study. PeerJ, 12, e18631. https://doi.org/10.7717/peerj.18631

Vancouver

Liu M, Liu P, Li J, Huang Y, Wu R. Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study. PeerJ. 2024;12:e18631. doi:10.7717/peerj.18631

BibTeX
@article{Liu2024,
  author = {Liu, Mengxia and Liu, Pengcheng and Li, JianBin and Huang, Yiping and Wu, Rui},
  title = {Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e18631},
  doi = {10.7717/peerj.18631}
}
Kostenlos starten →